Allergic Rhinitis Treatment and Management

Dear Colleagues, 

Allergic rhinitis (AR) is a common disease affecting 20–30% of the general population in industrialized countries. Allergic inflammation is the key to understanding the management of the disease and its comorbidities, such as conjunctivitis, asthma, etc.

Recent studies have focused on the inflammatory markers that are involved in allergic inflammation and the influence of different pharmacological therapies. Moreover, allergic inflammation is a hallmark feature of these diseases where different pathophysiological phenotypes are involved. Therefore, the identification of biomarkers which would describe the disease phenotype better are necessary, that may influence the precision medicine in AR such is allergen immunotherapy (AIT). Additionally, the quality of life (QoL) is very important to be influenced by those therapies, since QoL is highly affected in patients with moderate–severe persistent AR.

The purpose of this Special Issue is to highlight the importance of correct diagnosis and treatment in patients with AR and to reach some problems from impairment of QoL.

This Special Issue on “Allergic Rhinitis” is open for the publication of clinical and research data.

Prof. Dr. Ioana Adriana Muntean
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Sinusitis is an international peer-reviewed open access semiannually journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• QoL
• AIT
• AR
• diagnosis and treatment